• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接触生物战剂患者的临床识别与管理

Clinical recognition and management of patients exposed to biological warfare agents.

作者信息

Franz D R, Jahrling P B, Friedlander A M, McClain D J, Hoover D L, Bryne W R, Pavlin J A, Christopher G W, Eitzen E M

机构信息

US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Md, USA.

出版信息

JAMA. 1997 Aug 6;278(5):399-411. doi: 10.1001/jama.278.5.399.

DOI:10.1001/jama.278.5.399
PMID:9244332
Abstract

Concern regarding the use of biological agents--bacteria, viruses, or toxins--as tools of warfare or terrorism has led to measures to deter their use or, failing that, to deal with the consequences. Unlike chemical agents, which typically lead to violent disease syndromes within minutes at the site of exposure, diseases resulting from biological agents have incubation periods of days. Therefore, rather than a paramedic, it will likely be a physician who is first faced with evidence of the results of a biological attack. We provide here a primer on 10 classic biological warfare agents to increase the likelihood of their being considered in a differential diagnosis. Although the resultant diseases are rarely seen in many countries today, accepted diagnostic and epidemiologic principles apply; if the cause is identified quickly, appropriate therapy can be initiated and the impact of a terrorist attack greatly reduced.

摘要

对将生物制剂——细菌、病毒或毒素——用作战争或恐怖主义工具的担忧,促使人们采取措施阻止其使用,若无法阻止,则应对其后果。与化学制剂不同,化学制剂通常在接触部位数分钟内就会引发严重的疾病综合征,而生物制剂导致的疾病有几天的潜伏期。因此,首先面对生物攻击结果证据的很可能是医生,而非护理人员。我们在此提供一份关于10种经典生物战剂的入门指南,以增加在鉴别诊断中考虑到它们的可能性。尽管如今在许多国家很少见到由此引发的疾病,但公认的诊断和流行病学原则仍然适用;如果能迅速确定病因,就可以开始适当的治疗,并大大降低恐怖袭击的影响。

相似文献

1
Clinical recognition and management of patients exposed to biological warfare agents.接触生物战剂患者的临床识别与管理
JAMA. 1997 Aug 6;278(5):399-411. doi: 10.1001/jama.278.5.399.
2
Clinical recognition and management of patients exposed to biological warfare agents.接触生物战剂患者的临床识别与管理
Clin Lab Med. 2001 Sep;21(3):435-73.
3
Biological and chemical agents: a brief synopsis.生物和化学制剂:简要概述。
Am J Ther. 2002 Jan-Feb;9(1):5-14. doi: 10.1097/00045391-200201000-00003.
4
The threat of biological terrorism: a public health and infection control reality.生物恐怖主义的威胁:公共卫生与感染控制的现实情况。
Infect Control Hosp Epidemiol. 2000 Jan;21(1):53-6. doi: 10.1086/501700.
5
Confronting bioterrorism: physicians on the front line.应对生物恐怖主义:一线医生
Mayo Clin Proc. 2002 Jul;77(7):661-72. doi: 10.4065/77.7.661.
6
Medical aspects of bio-terrorism.生物恐怖主义的医学方面。
Toxicon. 2013 Jul;69:131-42. doi: 10.1016/j.toxicon.2013.01.005. Epub 2013 Jan 20.
7
Drugs and vaccines against biological weapons.针对生物武器的药物和疫苗。
Conn Med. 2001 Dec;65(12):719-20.
8
Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.组织病理学和免疫组织化学在生物恐怖主义制剂诊断中的应用
J Histochem Cytochem. 2006 Jan;54(1):3-11. doi: 10.1369/jhc.5R6756.2005. Epub 2005 Sep 7.
9
Preparedness for a bioterrorism event in Alaska. Part 1: Detection and identification of a biologic event.阿拉斯加应对生物恐怖主义事件的准备工作。第1部分:生物事件的检测与识别。
Alaska Med. 2000 Oct-Dec;42(4):101-13.
10
Bioterrorism.生物恐怖主义。
QJM. 2001 Apr;94(4):227-34. doi: 10.1093/qjmed/94.4.227.

引用本文的文献

1
Decoding the mechanophysiology for inhaled onset of smallpox with model-based implications for mpox spread.解码天花吸入传播的机械生理学,并基于模型探讨猴痘传播的影响。
medRxiv. 2025 Jun 20:2025.06.17.25329814. doi: 10.1101/2025.06.17.25329814.
2
Dentistry and Bioterrorism: A Legitimate Threat.牙科与生物恐怖主义:一种切实存在的威胁。
Cureus. 2024 May 9;16(5):e59958. doi: 10.7759/cureus.59958. eCollection 2024 May.
3
A bacteriophage-based validation of a personal protective equipment doffing procedure to be used with high-consequence pathogens.
一种基于噬菌体的高致病性病原体个人防护装备脱卸程序验证方法。
Infect Control Hosp Epidemiol. 2024 May 6;45(9):1-7. doi: 10.1017/ice.2024.84.
4
The rLVS Δ/ vaccine provides potent protection in Fischer rats against inhalational tularemia caused by various virulent strains.rLVSΔ/疫苗为费希尔大鼠提供了针对各种强毒菌株吸入性土拉菌病的有力保护。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2277083. doi: 10.1080/21645515.2023.2277083. Epub 2023 Nov 17.
5
Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques.埃博拉病毒黏膜挑战途径在食蟹猴中的特征分析。
J Virol. 2023 May 31;97(5):e0188822. doi: 10.1128/jvi.01888-22. Epub 2023 Mar 28.
6
Efficacy of ANTHRASIL (Anthrax Immune Globulin Intravenous (Human)) in rabbit and nonhuman primate models of inhalational anthrax: Data supporting approval under animal rule.炭疽免疫球蛋白静脉注射(人用)(ANTHRASIL)在兔和非人类灵长类动物吸入性炭疽模型中的疗效:支持根据动物规则批准的数据。
PLoS One. 2023 Mar 17;18(3):e0283164. doi: 10.1371/journal.pone.0283164. eCollection 2023.
7
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A.利用 mRNA 平台递呈单域抗体可预防致死剂量的A型肉毒神经毒素。
Front Immunol. 2023 Feb 14;14:1098302. doi: 10.3389/fimmu.2023.1098302. eCollection 2023.
8
Comprehensive characterization of toxins during progression of inhalation anthrax in a non-human primate model.吸入性炭疽病在非人类灵长类动物模型中进展过程中毒素的综合特征分析。
PLoS Pathog. 2022 Dec 19;18(12):e1010735. doi: 10.1371/journal.ppat.1010735. eCollection 2022 Dec.
9
A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.抗击传染病的军事医学策略历史回顾:从战场到全球健康
Biomedicines. 2022 Aug 22;10(8):2050. doi: 10.3390/biomedicines10082050.
10
Retrospective detection for V-type OPNAs exposure via phosphonylation and disulfide adducts in albumin.通过白蛋白中膦酸化和二硫键加合物对 V 型 OPNAs 暴露的回顾性检测。
Sci Rep. 2022 Jun 29;12(1):10979. doi: 10.1038/s41598-022-15198-3.